Zevin Asset Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.9M Sell
127,322
-2
-0% -$178 1.5% 33
2025
Q4
$10.1M Buy
127,324
+4,334
+4% +$340K 1.35% 32
2025
Q3
$9.83M Sell
122,990
-8,356
-6% -$713K 1.43% 29
2025
Q2
$11.9M Buy
131,346
+2,773
+2% +$253K 1.72% 25
2025
Q1
$12M Sell
128,573
-10,729
-8% -$961K 1.91% 23
2024
Q4
$12.7M Buy
139,302
+7,793
+6% +$744K 1.86% 21
2024
Q3
$13.7M Sell
131,509
-2,987
-2% -$304K 2.11% 19
2024
Q2
$13.1M Sell
134,496
-33,494
-20% -$3.09M 2.11% 19
2024
Q1
$15.1M Sell
167,990
-156
-0.1% -$13.2K 2.52% 16
2023
Q4
$13.4M Buy
168,146
+4,974
+3% +$374K 2.41% 17
2023
Q3
$11.6M Buy
163,172
+5
+0% +$374 2.33% 18
2023
Q2
$12.6M Sell
163,167
-765
-0.5% -$59.2K 2.52% 16
2023
Q1
$12.3M Sell
163,932
-1,937
-1% -$144K 2.51% 17
2022
Q4
$13.1M Buy
165,869
+8,860
+6% +$664K 2.84% 15
2022
Q3
$11M Buy
157,009
+6,981
+5% +$547K 2.61% 18
2022
Q2
$12M Buy
150,028
+1,496
+1% +$117K 2.71% 16
2022
Q1
$11.3M Buy
148,532
+61,019
+70% +$4.83M 2.16% 21
2021
Q4
$7.47M Sell
87,513
-2,098
-2% -$164K 1.35% 30
2021
Q3
$6.77M Buy
89,611
+8,306
+10% +$660K 1.29% 29
2021
Q2
$6.61M Buy
81,305
+6,486
+9% +$530K 1.32% 28
2021
Q1
$5.9M Buy
74,819
+4,124
+6% +$323K 1.3% 28
2020
Q4
$6.04M Buy
70,695
+1,059
+2% +$87.6K 1.42% 27
2020
Q3
$5.37M Buy
69,636
+2,504
+4% +$191K 1.47% 22
2020
Q2
$4.92M Sell
67,132
-107
-0.2% -$7.6K 1.49% 23
2020
Q1
$4.46M Buy
67,239
+4,925
+8% +$347K 1.66% 23
2019
Q4
$4.29M Sell
62,314
-1,249
-2% -$85.2K 1.32% 27
2019
Q3
$4.67M Buy
63,563
+1,451
+2% +$105K 1.51% 25
2019
Q2
$4.45M Sell
62,112
-1,040
-2% -$73.8K 1.43% 25
2019
Q1
$4.33M Sell
63,152
-2,400
-4% -$155K 1.41% 24
2018
Q4
$3.9M Sell
65,552
-8,062
-11% -$504K 1.42% 25
2018
Q3
$4.93M Buy
73,614
+1,062
+1% +$70.7K 1.44% 28
2018
Q2
$4.7M Sell
72,552
-2,973
-4% -$194K 1.4% 27
2018
Q1
$5.41M Sell
75,525
-1,126
-1% -$81K 1.41% 27
2017
Q4
$5.78M Sell
76,651
-10,281
-12% -$751K 1.31% 29
2017
Q3
$6.33M Sell
86,932
-107,243
-55% -$7.73M 1.49% 23
2017
Q2
$14.4M Sell
194,175
-17,777
-8% -$1.32M 3.63% 5
2017
Q1
$15.5M Sell
211,952
-42,940
-17% -$3.01M 3.93% 6
2016
Q4
$16.7M Buy
254,892
+175,406
+221% +$12M 4.35% 6
2016
Q3
$5.89M Buy
79,486
+29,116
+58% +$2.15M 1.9% 21
2016
Q2
$3.69M Buy
50,370
+2,525
+5% +$180K 1.02% 27
2016
Q1
$3.38M Buy
47,845
+743
+2% +$49.4K 0.96% 30
2015
Q4
$3.14M Buy
47,102
+305
+0.7% +$20.3K 0.83% 33
2015
Q3
$2.97M Buy
46,797
+2,295
+5% +$150K 0.87% 36
2015
Q2
$2.91M Buy
44,502
+1,060
+2% +$71.9K 0.78% 41
2015
Q1
$3.01M Buy
43,442
+180
+0.4% +$12.4K 0.83% 41
2014
Q4
$2.99M Buy
43,262
+1,266
+3% +$85.5K 0.84% 43
2014
Q3
$2.74M Buy
41,996
+2,450
+6% +$162K 0.8% 48
2014
Q2
$2.7M Buy
39,546
+245
+0.6% +$16.4K 0.79% 46
2014
Q1
$2.55M Sell
39,301
-21,776
-36% -$1.37M 0.8% 43
2013
Q4
$3.98M Buy
61,077
+609
+1% +$39K 1.13% 30
2013
Q3
$3.59M Buy
60,468
+7,975
+15% +$473K 1.1% 32
2013
Q2
$3.01M Buy
+52,493
New +$3.12M 1.04% 33

Other funds holding CL

Zevin Asset Management's CL Position: Q1 2026 in Review

Zevin Asset Management reduced its Colgate-Palmolive (CL) stake by 0% in Q1 2026, selling an estimated $178 and leaving 127,322 shares worth $10.9M. The position accounts for 1.5% of the portfolio, ranked #33.

Zevin Asset Management first reported a position in CL in Q2 2013 and has held it in 52 quarters since. The position peaked at $16.7M in Q4 2016. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Zevin Asset Management held 127,322 shares of Colgate-Palmolive worth $10.9M as of Q1 2026.
  • Zevin Asset Management sold 2 Colgate-Palmolive shares in Q1 2026, an estimated $178.
  • Colgate-Palmolive made up 1.5% of Zevin Asset Management's portfolio in Q1 2026, its #33 holding.
  • Zevin Asset Management first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 52 quarters since.
  • Zevin Asset Management's Colgate-Palmolive position peaked at $16.7M in Q4 2016.
  • 1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Zevin Asset Management's 13F filing for Q1 2026, filed 7 May 2026.